Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): A$0.04960

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is A$0.05126. In 2025 the company made an earnings per share (EPS) of A$0.02671 a decrease over its 2024 EPS that were of A$0.03761.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2025	A$0.02671	-29%
2024	A$0.03761	47.17%
2023	A$0.02556	-9.68%
2022	A$0.02830	-83.86%
2021	A$0.18	440.46%
2020	A$0.03243	7.54%
2019	A$0.03016	-70.37%
2018	A$0.10	254.37%
2017	A$0.02872	41.55%
2016	A$0.02029	2.59%
2015	A$0.01978	17.63%
2014	A$0.01681	45.97%
2013	A$0.01152	16.34%
2012	A$0.009900	93.4%
2011	A$0.005119	-20.02%
2010	A$0.006400	33.16%
2009	A$0.004807	774.72%
2008	A$0.0005495	-79.69%
2007	A$0.002706	58.8%
2006	A$0.001704	-91.05%
2005	A$0.01903	723.97%
2004	A$0.002310	105.48%
2003	A$0.001124	-67.27%
2002	A$0.003434	-8.26%
2001	A$0.003744	17.18%
2000	A$0.003195	-4.62%
1999	A$0.003350

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)